期刊文献+

卡托普利和低剂量阿司匹林在犬体内的药动学相互作用研究 被引量:3

Pharmacokinetics interaction of captopril and low-dosage aspirin in dog
下载PDF
导出
摘要 目的观察卡托普利和低剂量阿司匹林在犬体内的药动学相互作用。方法采用6只雄性健康犬进行随机交叉试验, 对犬单用卡托普利(30 mg·kg-1)、阿司匹林(1.5 mg·kg-1)及合用两药时的主要药动学参数进行比较。分别采用反相高效液相色谱法测定犬血浆中卡托普利及水杨酸浓度,药-时数据应用3P87程序经计算机拟合处理。结果与单用时相比,合用阿司匹林后卡托普利的消除速率常数(Ke)显著增加,消除半衰期(t1/2Ke)明显缩短,但血药浓度峰值(cmax)、血药浓度达峰时间(tmax)、药-时曲线下面积(AUC)无显著性差异。而阿司匹林单用及联用卡托普利时的药动学参数均无显著性差异。结论低剂量阿司匹林联用卡托普利明显影响卡托普利的有关药动学参数,而阿司匹林本身不受影响,是否诱导卡托普利相关的药酶代谢值得进一步研究。 OBJECTIVE: To observe the pharmacokinetic interaction between captopril and low-dosage aspirin in dog. METHODS: The main pharmacokinetic parameters of captopril(30 mg&middotkg-1), aspirin (1.5 mg&middotkg-1) and their combination were comparatively investigated in an open randomized crossover study. Drug concentration in plasma was assayed by RP-HPLC method. Concentration-time curves were simulated by 3P87 program. RESULTS: Compared with the group treated with captopril alone, Ke increased significantly and t 1/2 decreased significantly in the group with combined treatment. There was no significant difference in cmax, tmax and AUG. No statistical significant difference was found in the pharmacokinetic parameters between the group treated with aspirin alone and in the group with combined treatment. CONCLUSIONS: The results suggested that aspirin stimulated the activity of drug-metabolizing enzymes and produced pharmacokinetic interaction with captopril, which resulted in the differences in Ke, t 1/2Ke and AUC of captopril. However, there was no effect on aspirin itself.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第9期696-698,共3页 Chinese Pharmaceutical Journal
关键词 卡托普利 阿司匹林 药动学 药物相互作用 Bioassay Drug products Enzymes High performance liquid chromatography Metabolism Pharmacokinetics
  • 相关文献

参考文献8

二级参考文献12

共引文献42

同被引文献19

  • 1董素琴.常量阿斯匹林治疗风湿性疾病致水杨酸中毒[J].甘肃医药,1994,13(4):229-230. 被引量:1
  • 2陈颖.浅谈药物相互作用[J].中国临床医生杂志,2005,33(4):46-48. 被引量:9
  • 3向柏,潘振华,曹德英.复方丹参滴丸质量控制和药理学研究进展[J].中国药房,2007,18(9):708-710. 被引量:15
  • 4Weiss H J. Discovery of the antiplatelet effect of aspirin: a personal reminiscence[J]. J Thromb Haemost, 2003,1 : 1869-1875. 被引量:1
  • 5Alberts M J,Bergman D L,Molner E,Jovanovic B D,Ushiwata I, Teruya J. Antiplatelet effect of aspirin in patients with cere- brovascular disease [J]. Stroke, 2004,35 : 175-178. 被引量:1
  • 6GILMAN M T,VIVIEN E P, JOHN W,et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A4 phosphate : Intravital microscopy and measurement of vascular permeabilityl [J]. Cancer Res,2001,61:6413-6422. 被引量:1
  • 7CATHY M W, VIJAYARAGAVAN M, STEWART S, et al. Combretastatin A4 prodrug study of effect on the growth and the microvascttlature of colorectal liver metastases in a murine modell [J]. Clin Cancer Res ,2001,7 : 1052-1060. 被引量:1
  • 8TSAI T H, CHEN Y F, SHUM A Y C,et al. Determination of chlorogenic acid in rat blood by microdialysis coupled with microbore liquid chromatography and its application to pharmacokinetic studies [ J ]. J Chromatography A ,2000,870:443 -448. 被引量:1
  • 9GORDON B Y,RUSTIN J S, SUSAN M, et al. Phase Ⅰ clinical trial of weekly combretastatin A4 phosphate:clinical and pharmacokinetic results[J]. J Clin Oncol,2003,21:2815-2822. 被引量:1
  • 10柴志强,魏立,丁钰.复方丹参滴丸干预阿司匹林抵抗的临床试验[J].实用医药杂志,2008,25(4):387-389. 被引量:25

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部